Poland· PL-100134246
Risperon
A risperidone product containing risperidonum, registered in Poland by Przedsiębiorstwo Farmaceutyczne LEK-AM Sp. z o.o.. The same ATC class is registered in 19 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Risperidone is registered in 19 of 19 countries.
Countries holding a registration under ATC N05AX08 (risperidone), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 11 of them publish a price we can compare per daily dose
Risperidone · ATC N05AX08
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of risperidone costs, country by country.
Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.52 in Czechia to $3.93 in Switzerland — a ×7.5 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Risperidone · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$3.93
- IT Italy$1.34
- FR France$0.77
- CZ Czechia$0.52
The record
At a glance
URPL (Poland)- Active substance
- Risperidonum
- Manufacturer
- Przedsiębiorstwo Farmaceutyczne LEK-AM Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- N05AX08
- ATC class
- Risperidone
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 7
2 priced- gtin05909991126711
- gtin05909991126728
- gtin05909991126735
- gtin0590999033658620 szt.PLN 36.19
- gtin0590999033660960 szt.PLN 100.24
- gtin05909991126742
- gtin05909990336593
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
542 interactions on record for risperidone.
Graded by severity as the source publishes them — 45 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Risperidone · interactions on record
542 records
- 45 severe
- 286 moderate
- 4 minor
- 136 info
Most severe, free to view
- MetoclopramideA03FA01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- PasireotideH01CB05severe
71 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Risperidone in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandApadoratMedis-Danmark A/S
- FranceRISPERDAL 4 mg, comprimé pelliculéJANSSEN CILAG
- CzechiaRISPERDALJanssen-Cilag s.r.o., Praha
- SwedenMedorisper 4 mg Filmdragerad tablettMedochemie Ltd
- NetherlandsRisperdal 4 mg, filmomhulde tablettenJanssen-Cilag B.V.
- BelgiumRisperdal 4 mgPI Pharma
- SwitzerlandRisperdal 4 mg, FilmtablettenJanssen-Cilag AG
- United StatesrisperidoneZydus Pharmaceuticals USA Inc.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Risperdal, Risperdal Consta
- Belgium · Risperdal, Risperdal Consta
- Bulgaria · Медориспер, Рисар
- Cyprus · Eperon, Risperdal
- Czechia · Medorisper, Rileptid
- Germany · Risperdal, Risperdal Consta
- Denmark · Rispemyl, Risperanne
- Estonia · Medorisper, Risperidon Actavis
- Spain · Arketin, Risperdal
- Finland · Rismyl, Risperdal
- France · Risperdal, Risperdalconsta L.P.
- United Kingdom (Northern Ireland) · Risperdal Consta, Risperidione Wockhardt Uk Ltd
- Greece · Adovia, Axelabron
- Croatia · Prospera, Risdonal
- Hungary · Perdox, Rileptid
- Ireland · Perdamel, Risperdal
- Iceland · Okedi, Ríson
- Italy · Risperdal, Risperidone Aurobindo
- Liechtenstein · Okedi, Risperdal Consta
- Lithuania · Medorisper, Risperidon Actavis
- Luxembourg · Risperdal, Risperdal Consta
- Latvia · Medorisper, Rispaxol
- Malta · Eperon, Evitrat
- Netherlands · Risperdal, Risperdal Consta
- Norway · Okedi, Risperdal
- Portugal · Risperdal, Risperdal Consta
- Romania · Rispen, Risperidonă Arena
- Sweden · Medorisper, Rispemyl
- Slovenia · Risperdal, Risperdal Consta
- Slovakia · Medorisper, Rispen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f532b9ef-56d2-45a8-b4ac-72748d1a6260 GET /v1/drugs/f532b9ef-56d2-45a8-b4ac-72748d1a6260?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "4 mg",
"packaging": "05909991126711 ¦ Rp ¦ Skasowane ¦ 26368\n10 tabl. w blistrze\n05909991126728 ¦ Rp ¦ Skasowane ¦ 26369\n20 tabl. w pojemniku\n05909991126735 ¦ Rp ¦ Skasowane ¦ 26370\n40 tabl. w pojemniku\n05909991126742 ¦ Rp ¦ Skasowane ¦ 26371\n60 tabl. w pojemniku\n05909990336586 ¦ Rp ¦ 31998\n20 tabl.\n05909990336593 ¦ Rp ¦ Skasowane ¦ 31999\n40 tabl.\n05909990336609 ¦ Rp ¦ 32000\n60 tabl.",
"substance": "Risperidonum 4 mg",
"common_name": "Risperidonum",
"pl_product_id": "100134246",
"pozwolenie_nr": "11267",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about risperidone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.